Keros Therapeuticsinc Stock Price Prediction

KROS Stock  USD 57.51  1.17  1.99%   
At this time, the RSI of Keros TherapeuticsInc's share price is approaching 37. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Keros TherapeuticsInc, making its price go up or down.

Oversold Vs Overbought

37

 
Oversold
 
Overbought
Keros TherapeuticsInc stock price prediction is an act of determining the future value of Keros TherapeuticsInc shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Keros TherapeuticsInc's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Keros TherapeuticsInc and does not consider all of the tangible or intangible factors available from Keros TherapeuticsInc's fundamental data. We analyze noise-free headlines and recent hype associated with Keros TherapeuticsInc, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Keros TherapeuticsInc's stock price prediction:
EPS Estimate Next Quarter
(1.33)
EPS Estimate Current Year
(5.27)
EPS Estimate Next Year
(5.47)
Wall Street Target Price
88.88
EPS Estimate Current Quarter
(1.37)
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Keros TherapeuticsInc based on different types of headlines from major news networks to social media. The Keros stock price prediction module provides an analysis of price elasticity to changes in media outlook on Keros TherapeuticsInc over a specific investment horizon. Using Keros TherapeuticsInc hype-based prediction, you can estimate the value of Keros TherapeuticsInc from the perspective of Keros TherapeuticsInc response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Keros TherapeuticsInc using Keros TherapeuticsInc's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Keros using crowd psychology based on the activity and movement of Keros TherapeuticsInc's stock price.

Keros TherapeuticsInc Implied Volatility

    
  0.0  
Keros TherapeuticsInc's implied volatility exposes the market's sentiment of Keros TherapeuticsInc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Keros TherapeuticsInc's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Keros TherapeuticsInc stock will not fluctuate a lot when Keros TherapeuticsInc's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Keros TherapeuticsInc. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Keros TherapeuticsInc to buy its stock at a price that has no basis in reality. In that case, they are not buying Keros because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Keros TherapeuticsInc after-hype prediction price

    
  USD 58.09  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Keros TherapeuticsInc Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Keros Stock please use our How to Invest in Keros TherapeuticsInc guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Keros TherapeuticsInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
52.8169.7272.96
Details
Naive
Forecast
LowNextHigh
58.3661.6064.85
Details
10 Analysts
Consensus
LowTargetHigh
80.8688.8698.63
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.62-1.35-1.2
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Keros TherapeuticsInc. Your research has to be compared to or analyzed against Keros TherapeuticsInc's peers to derive any actionable benefits. When done correctly, Keros TherapeuticsInc's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Keros TherapeuticsInc.

Keros TherapeuticsInc After-Hype Price Prediction Density Analysis

As far as predicting the price of Keros TherapeuticsInc at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Keros TherapeuticsInc or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Keros TherapeuticsInc, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Keros TherapeuticsInc Estimiated After-Hype Price Volatility

In the context of predicting Keros TherapeuticsInc's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Keros TherapeuticsInc's historical news coverage. Keros TherapeuticsInc's after-hype downside and upside margins for the prediction period are 54.85 and 61.33, respectively. We have considered Keros TherapeuticsInc's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
57.51
58.09
After-hype Price
61.33
Upside
Keros TherapeuticsInc is very steady at this time. Analysis and calculation of next after-hype price of Keros TherapeuticsInc is based on 3 months time horizon.

Keros TherapeuticsInc Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Keros TherapeuticsInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Keros TherapeuticsInc backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Keros TherapeuticsInc, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.27 
3.24
  0.59 
  0.02 
7 Events / Month
13 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
57.51
58.09
1.01 
147.95  
Notes

Keros TherapeuticsInc Hype Timeline

Keros TherapeuticsInc is now traded for 57.51. The entity has historical hype elasticity of -0.59, and average elasticity to hype of competition of 0.02. Keros is estimated to decline in value after the next headline, with the price expected to drop to 58.09. The average volatility of media hype impact on the company price is about 147.95%. The price decrease on the next news is expected to be -1.01%, whereas the daily expected return is now at 0.27%. The volatility of related hype on Keros TherapeuticsInc is about 4800.0%, with the expected price after the next announcement by competition of 57.53. About 88.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 5.2. Keros TherapeuticsInc had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 7 days.
Check out Keros TherapeuticsInc Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Keros Stock please use our How to Invest in Keros TherapeuticsInc guide.

Keros TherapeuticsInc Related Hype Analysis

Having access to credible news sources related to Keros TherapeuticsInc's direct competition is more important than ever and may enhance your ability to predict Keros TherapeuticsInc's future price movements. Getting to know how Keros TherapeuticsInc's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Keros TherapeuticsInc may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
IDYAIdeaya Biosciences(0.50)10 per month 0.00 (0.04) 3.41 (4.35) 10.71 
ANABAnaptysBio 0.92 9 per month 3.67  0.05  11.29 (6.34) 22.98 
MGTXMeiraGTx Holdings PLC 0.04 10 per month 0.00 (0.09) 5.48 (4.82) 16.66 
FIXXHomology Medicines 0.07 5 per month 11.22  0.12  10.00 (3.26) 1,764 
JANXJanux Therapeutics 3.17 10 per month 2.60  0.17  14.00 (6.33) 240.08 
FENCFennec Pharmaceuticals(0.12)10 per month 0.00 (0.08) 2.64 (2.78) 16.83 
EWTXEdgewise Therapeutics 0.08 10 per month 3.24  0.02  5.44 (5.19) 17.83 
HRMYHarmony Biosciences Holdings 0.05 7 per month 2.33 (0.01) 4.78 (4.70) 12.07 
AVTEAerovate Therapeutics 0.30 9 per month 5.02  0.05  11.11 (8.70) 28.53 
SNDXSyndax Pharmaceuticals 0.62 10 per month 2.64  0.05  4.69 (4.67) 13.10 
MLYSMineralys Therapeutics Common(0.26)7 per month 3.08  0.03  6.18 (5.15) 22.93 
REPLReplimune Group(0.34)8 per month 0.00 (0.04) 5.95 (6.62) 19.26 
ERASErasca Inc 0.08 9 per month 3.60  0.09  7.14 (6.31) 25.03 
IPSCCentury Therapeutics(0.14)8 per month 0.00 (0.02) 8.37 (9.48) 32.09 
NGMGIGAMON 0.00 0 per month 3.60  0.1  6.54 (4.29) 39.15 
GLUEMonte Rosa Therapeutics(1.96)9 per month 6.99  0.06  10.88 (8.88) 38.28 
SRZNSurrozen 0.66 9 per month 6.94  0.07  13.41 (7.11) 53.13 
BOLTBolt Biotherapeutics 0.00 5 per month 3.21 (0.01) 6.40 (5.83) 21.42 
LRMRLarimar Therapeutics(1.29)9 per month 4.40  0.08  11.04 (6.45) 52.23 
KZRKezar Life Sciences(0.03)9 per month 0.00 (0.06) 7.22 (5.81) 15.51 

Keros TherapeuticsInc Additional Predictive Modules

Most predictive techniques to examine Keros price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Keros using various technical indicators. When you analyze Keros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Keros TherapeuticsInc Predictive Indicators

The successful prediction of Keros TherapeuticsInc stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Keros TherapeuticsInc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Keros TherapeuticsInc based on analysis of Keros TherapeuticsInc hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Keros TherapeuticsInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Keros TherapeuticsInc's related companies.
 2022 2023 2024 (projected)
Days Sales Outstanding2.6K2.4K2.5K
PTB Ratio4.373.523.35

Story Coverage note for Keros TherapeuticsInc

The number of cover stories for Keros TherapeuticsInc depends on current market conditions and Keros TherapeuticsInc's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Keros TherapeuticsInc is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Keros TherapeuticsInc's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Keros TherapeuticsInc Short Properties

Keros TherapeuticsInc's future price predictability will typically decrease when Keros TherapeuticsInc's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Keros TherapeuticsInc often depends not only on the future outlook of the potential Keros TherapeuticsInc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Keros TherapeuticsInc's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding29.4 M
Cash And Short Term Investments331.1 M
When determining whether Keros TherapeuticsInc is a strong investment it is important to analyze Keros TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Keros TherapeuticsInc's future performance. For an informed investment choice regarding Keros Stock, refer to the following important reports:
Check out Keros TherapeuticsInc Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Keros Stock please use our How to Invest in Keros TherapeuticsInc guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Keros Stock analysis

When running Keros TherapeuticsInc's price analysis, check to measure Keros TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros TherapeuticsInc is operating at the current time. Most of Keros TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Keros TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros TherapeuticsInc's price. Additionally, you may evaluate how the addition of Keros TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Transaction History
View history of all your transactions and understand their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Keros TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Keros TherapeuticsInc. If investors know Keros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Keros TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.20)
Revenue Per Share
0.005
Return On Assets
(0.31)
Return On Equity
(0.50)
The market value of Keros TherapeuticsInc is measured differently than its book value, which is the value of Keros that is recorded on the company's balance sheet. Investors also form their own opinion of Keros TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Keros TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Keros TherapeuticsInc's market value can be influenced by many factors that don't directly affect Keros TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Keros TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Keros TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Keros TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.